Your browser doesn't support javascript.
loading
Testing NF-kappa B1-p50 antibody specificity using knockout mice.
Pereira, D S; Kushner, D B; Ricciardi, R P; Graham, F L.
Affiliation
  • Pereira DS; Department of Biology, McMaster University, Hamilton, Ontario, Canada.
Oncogene ; 13(2): 445-6, 1996 Jul 18.
Article in En | MEDLINE | ID: mdl-8710386
ABSTRACT
Cell extracts from knockout mice can provide definitive proof of antibody specificity. Two NF-kappa B1-p50 antibodies, sc-114 (a commercial antibody) and NR1157, were observed to recognize proteins having distinct electrophoretic mobilities of 52-55 kD and 50 kD, respectively, by Western blot analysis. In order to discriminate the specificity of these antibodies for NF-kappa B1-p50, whole cell extracts derived from NF-kappa B1-p105 knockout mice were employed. While the NR1157 antibody completely failed to recognize its 50 kD product in p105-/- knockout extracts, the sc-114 antibody still strongly recognized its 52-55 kD product. These data demonstrate that NR1157, but not sc-114, is highly specific for NF-kappa B1-p50 by Western blot analysis. In addition, these results highlight the utility of knockout cell extracts for discerning antibody specificity.
Subject(s)
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: NF-kappa B / Antibodies / Antibody Specificity Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 1996 Type: Article Affiliation country: Canada
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: NF-kappa B / Antibodies / Antibody Specificity Limits: Animals / Humans Language: En Journal: Oncogene Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 1996 Type: Article Affiliation country: Canada